• About
    • Our Team
    • Our Partners
    • Our Work
  • Tools
    • Case Definitions
    • Vaccine Safety Templates
    • BRAVATO
    • Translations
  • Resources
    • News
    • Newsletter
    • Safety by Numbers
    • Webinars
  • Training
    • DSMB Training
    • CDC Training​
    • Vaccine Courses
  • SPEAC
Menu
  • About
    • Our Team
    • Our Partners
    • Our Work
  • Tools
    • Case Definitions
    • Vaccine Safety Templates
    • BRAVATO
    • Translations
  • Resources
    • News
    • Newsletter
    • Safety by Numbers
    • Webinars
  • Training
    • DSMB Training
    • CDC Training​
    • Vaccine Courses
  • SPEAC
ebola
JOIN
Posted on April 13, 2008September 14, 2023

A local reaction at or near injection site

The need for developing a case definition and guidelines for a local reaction at or near the injection site, methods for the devel...
Read More
Posted on August 13, 2007September 14, 2023

Abscess at injection site

Need for developing case definitions and guidelines for abscess at injection site as an adverse events following immunization:...
Read More
Posted on July 13, 2007September 14, 2023

Cellulitis at injection site

Need for developing case definitions and guidelines for cellulitis at injection site as an adverse events following immunization...
Read More
Posted on June 13, 2007September 14, 2023

Induration at or near injection site

Need for developing a standardized case definition and guidelines for induration at or near injection site as an adverse event fol...
Read More
Posted on April 13, 2007September 14, 2023

Swelling at or near injection site

Need for developing a standardized case definition and guidelines for swelling at or near injection site as an adverse events foll...
Read More
Posted on January 13, 2006September 14, 2023

Nodule at injection site as an adverse event following immunization

To improve comparability of vaccine safety data the Brighton Collaboration Local Reactions Working Group has developed a case defi...
Read More

Recent Posts

  • Brighton Collaboration News — Summer 2026August 31, 2026
  • Fetal VacciniaAugust 10, 2026
  • Acute Intraocular InflammationJuly 1, 2026
  • Acute Multi-Organ DysfunctionJune 2, 2026
  • WHO Resource References Brighton Collaboration StandardsMay 11, 2026

Most Recent Posts

  • Brighton Collaboration News — Summer 2026August 31, 2026
  • Fetal VacciniaAugust 10, 2026
  • Acute Intraocular InflammationJuly 1, 2026

Posts

  • Brighton Collaboration News — Summer 2026
  • Fetal Vaccinia
  • Acute Intraocular Inflammation
  • Acute Multi-Organ Dysfunction
  • WHO Resource References Brighton Collaboration Standards
  • Request for Review: Acute Multi-Organ Dysfunction (aMOD) Brighton Case Definition
  • In Memory of Dr. William Foege
  • Brighton Collaboration News — December 2025
  • Request for Review: Acute Intraocular Inflammation Draft Brighton Case Definition
  • Standardized template with key considerations for a benefit/risk assessment for the emergent vesicular stomatitis virus (VSV) viral vector vaccine for Lassa fever
Download.pdf
Download.txt

Contact us for help?

Contact with us through our representative or submit a business inquiry online.

Contact Us

Email:
bc-coordinator@taskforce.org

Address:
The Task Force for Global Health,
330 W. Ponce de Leon Ave.
Decatur, GA 30030

  • Case Definitions
  • Safety Templates
  • Covid-19
  • Trusted Sources
Linkedin

© Brighton Collaboration  2023. All rights reserved.

  • Disclaimer and Privacy Policy